Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 13801 - 13825 of 14939 in total

AGIL-FA

Investigational

Latozinemab

Investigational

BLS-M22

Investigational

TSHA-118

TSHA-118 is a self-complementary AAV9 gene replacement therapy designed to express a human codon-optimized CLN1 transgene for the treatment of CLN1 disease.
Experimental

PR006

PR006 is a non-replicating recombinant adeno-associated virus serotype 9 containing the progranulin gene. It is being investigated for the treatment of dementia.
Investigational

BMN-044

Experimental
Withdrawn

BMN-046

Experimental
Withdrawn

Alirinetide

Investigational

BMN-055

Experimental
Withdrawn

CTI-1601

Investigational

GliSODin

Investigational
Nutraceutical

Darleukin

Investigational

MTI-201

Investigational

Algenpantucel-L

Investigational

GTA002

Investigational

CE-VST01-JC

Investigational

KITE-222

Investigational

DP-303c

Investigational

Murlentamab

Investigational

Lerapolturev

Investigational

ALT-P7

Investigational

G100

Investigational

MGD-024

MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.
Investigational

ST-36

ST-36 is a cell-penetrating dominant-negative form of activating transcription factor 5. In 2017, it received orphan drug designation by the FDA for the treatment of glioma.
Investigational

IMAB027

IMAB027 is a chimeric monoclonal antibody against Claudin 6.
Investigational
Displaying drugs 13801 - 13825 of 14939 in total